Supplementary data 1 from Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis
IntroductionAnalyzing liquid biopsies for tumor-specific aberrations can facilitate detection of measurable residual disease (MRD) during treatment and at follow-up. In this study, we assessed the cli
This dataset provides details of the data supporting the claims of the related manuscript: “Exploring the characteristics of circulating tumor DNA in pT1a clear cell renal cell carcinoma: a pilot stud
This dataset provides details of the data supporting the claims of the related manuscript: “Exploring the characteristics of circulating tumor DNA in pT1a clear cell renal cell carcinoma: a pilot stud
